Problematic Anxiety in Parkinson’s Disease (2021)

In this talk presented at Parkinson Society British Columbia’s 2020 Annual General Meeting, Dr. Andrew Howard, a clinical associate professor in the Department of Psychiatry at the University of British Columbia, focused on the pervasive nature of anxiety in Parkinson's disease and its impact on patients' daily lives.

The discussion highlighted the lack of comprehensive research on anxiety despite its early onset in Parkinson's, emphasizing the need for further exploration into its origins and implications. While cognitive-behavioural therapy (CBT) was presented as the primary treatment for anxiety, the talk also mentioned the limited evidence for pharmacological approaches, alternative therapies like mindfulness, and the potential roles of cannabinoids and probiotics in managing anxiety.

It was advised that antipsychotics are generally avoided due to their adverse effects on motor symptoms, with the exception of quetiapine. Carepartners were encouraged to actively participate in therapy sessions to acquire essential skills for supporting individuals dealing with anxiety in Parkinson's.

View the video slides accompanying this presentation by clicking here.

**Disclaimer: These sessions are designed to provide general education and are not intended for individual advice and/or clinical care. The information conveyed in this recording was accurate at the time of presentation.**